title: [Vigabatrin-induced cytolytic hepatitis].
authors.forename: C
authors.initials: C
authors.lastname: Locher
authors.forename: E S
authors.initials: ES
authors.lastname: Zafrani
authors.forename: D
authors.initials: D
authors.lastname: Dhumeaux
authors.forename: A
authors.initials: A
authors.lastname: Mallat
mesh_terms: D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000209:etiology*; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D020888:Vigabatrin / Q000009:adverse effects*
chemical_list: D004791:Enzyme Inhibitors; D000612:4-Aminobutyrate Transaminase; D000410:Alanine Transaminase; D020888:Vigabatrin; D001663:Bilirubin
vernacular_title: Hépatite aiguë cytolytique induite par le vigabatrin.